drugset / Trial / NCT00487968

Eltrombopag Taste Testing in Healthy Adult Volunteers

NCT00487968

Phase 1 Completed 12 enrolled GlaxoSmithKline
RandomizedSingle-groupSingle-blindTreatment

Summary

Based on a need for a pediatric formulation of eltrombopag for the treatment of pediatric thrombocytopenia, this study will help determine the best tasting pediatric formulation of eltrombopag. Healthy adult volunteers who are able to taste bitterness and who do not have a high sensitivity to bitterness will be enrolled. The subjects will evaluate different formulations and rate them based on the bitterness and effectiveness of sweetners. The outcome of this study will help support a decision for a new pediatric formulation of eltrombopag.

Timeline

Start
2007-05
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Eltrombopag Small molecule